ELEV – elevation oncology, inc. - common stock (US:NASDAQ)
Stock Stats
News
Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Form SC 13G/A Elevation Oncology, Inc. Filed by: Aisling Capital IV, LP
Form SC 13G/A Elevation Oncology, Inc. Filed by: VANGUARD GROUP INC
Form SC 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Form SC 13G Elevation Oncology, Inc. Filed by: GOLDMAN SACHS GROUP INC
Form 8-K Elevation Oncology, Inc. For: Nov 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.